Infants born before 32 weeks of gestation or with respiratory disease are most likely to receive palivizumab in the Netherlands.
about
Infants born before 32 weeks of gestation or with respiratory disease are most likely to receive palivizumab in the Netherlands.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Infants born before 32 weeks o ...... alivizumab in the Netherlands.
@en
type
label
Infants born before 32 weeks o ...... alivizumab in the Netherlands.
@en
prefLabel
Infants born before 32 weeks o ...... alivizumab in the Netherlands.
@en
P2093
P2860
P356
P1433
P1476
Infants born before 32 weeks o ...... alivizumab in the Netherlands.
@en
P2093
Fernie J A Penning-van Beest
Irene D Bezemer
Leanne M A Kool-Houweling
Richard A van Lingen
Ron M C Herings
P2860
P304
P356
10.1111/APA.13081
P407
P577
2015-06-13T00:00:00Z